Eurocine Vaccines AB (publ) engages in the development of vaccines in Sweden. The company is developing Herpes Simplex Virus type 2 and Chlamydia vaccines. Eurocine Vaccines AB (publ) was incorporated in 1999 and is based in Solna, Sweden.
Stock data | 2025 | Change |
---|---|---|
Price | $0.051951560864353846 | N/A |
Market Cap | $4.97M | N/A |
Shares Outstanding | 95.67M | N/A |
Employees | 3.00 | N/A |